| Random sequence generation (selection bias) |
Low risk |
Quote: “Randomization into the trial is in blocks of 8, using an automated system, with the 8 groups reflecting the 8 combinations of prenatal and infancy supplements” |
|
Comment: Adequately done |
| Allocation concealment (selection bias) |
Low risk |
Quote: “Each box of supplement is then distinguished by a number between 1 and 8” |
|
Comment: Adequately done |
| Blinding of participants and personnel (performance bias) |
High risk |
Quote: “Since it is not be possible to blind the field assistants or the women to the supplement type (tablet vs. LNS); all other investigators however will not know to which group the women belong” |
|
Comment: Not adequately done |
| Blinding of outcome assessment (detection bias) |
Low risk |
Quote: “Since it is not be possible to blind the field assistants or the women to the supplement type (tablet vs. LNS); all other investigators however will not know to which group the women belong” |
|
Comment: Adequately done |
| Incomplete outcome data (attrition bias) |
High risk |
Comment: 159/620 × 100 = 25.64% |
| Selective reporting (reporting bias) |
Unclear risk |
Comment: Published protocol not found. The outcomes specified in the methodology section have been reported in the results section |
| Other bias |
Low risk |
Comment: No other potential sources of bias reported |
| Was the allocation sequence adequately generated? |
Unclear risk |
|
| Was the allocation adequately concealed? |
Unclear risk |
|
| Were baseline outcome measurements similar? |
Unclear risk |
|
| Were baseline characteristics similar? |
Unclear risk |
|
| Were incomplete outcome data adequately addressed? |
Unclear risk |
|
| Was knowledge of the allocated intervention adequately prevented during the study? |
Unclear risk |
|
| Was the study adequately protected against contamination? |
Unclear risk |
|
| Was the study free from selective outcome reporting? |
Unclear risk |
|
| Was the study free from other risk of bias? |
Unclear risk |
|